 "Q2 earnings, Q2 result")
Procter & Gamble Health (P&G Health) saw its net profit rise 8 per cent in the July–September quarter to Rs 89 crore, while sales increased 3 per cent to Rs 319 crore.
The company said sales in the quarter ended September were supported by strong brand fundamentals and positive consumer response to new innovations.
Balanced growth across top and bottom line
Milind Thatte, managing director, P&G Health India, said in a statement:
“We are pleased with the sustained growth momentum after a strong start to FY2025–26, with balanced growth across both top line and bottom line for the second consecutive quarter.”
Also Read
 "P&G")
 "From its highs over the past month, the stock of Procter & Gamble Hygiene and Healthcare is down 7 per cent before recovering this week P&G")
 "q1 results, company quarter 1")
 "Shailesh Jejurikar (left) with his mother Veena Jejurikar (center) and Rajesh Jejurikar, ED and CEO, auto and farm sectors, M&M | Source: Jejurikar family")
Innovation and consumer engagement drive momentum
He added: “This is driven by strategic efforts across the value chain, including a strategic consumer communication initiative on Evion and Seven Seas, and the introduction of new products like the Livogen Iron Gummies and Neurobion Nerve Pain Relief Cream, among others.
Further, we continue to strengthen our supply chain capabilities, ensuring we address the evolving needs of our consumers, customers, and healthcare professionals through superior brand building, go-to-market initiatives, and innovations backed by science.”
 "CSB BAnk")
 "Embassy Reit delivers returns of more than 20% since market debut")
 "Honeywell")
 "Orient Green Power Company")
 "Sun Pharma")
